oral glp-1 medications Comparing Ozempic, Wegovy and Other Drugs glp-1 drugs oral Oral GLP-1

The vial can be kept at room temperature for short periods, such as during travel or immediately before injection, but prolonged exposure to room temperature should be avoided

According to Novo Nordisk, a 64-week clinical trial with over 300 participants found that those with obesity or overweight who took the oral Wegovy pill once a day lost an average of 16.6% of their body weight for people who completed the trial, a similar amount to those who took the injectable form of Wegovy, which launched in 2021, on a weekly basis

Reported example tiers for GLP-1s in public discussions include lower-cost monthly injectables and starter oral pricing that significantly cut initial costs

doi:10.1124/pr.115.011395 39

This dual-hormone action makes GLP-1 clinically superior for weight loss, with trials showing up to 22% body weight reduction versus 1215% for Ozempic